Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001902797-22-000002
Filing Date
2022-02-14
Accepted
2022-02-14 11:41:27
Documents
1
Effectiveness Date
2022-02-14
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 13367
  Complete submission text file 0001902797-22-000002.txt   14485
Mailing Address 25 EAST ERIE STREET CHICAGO IL 60611
Business Address 25 EAST ERIE STREET CHICAGO IL 60611 312-587-3800
Driehaus Life Sciences Fund, L.P. (Filer) CIK: 0001766919 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-332572 | Film No.: 22627491